These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 35834034)
1. MicroRNA-155 expression is associated with pulpitis progression by targeting SHIP1. Li B; Guo L; He Y; Tu X; Zhong J; Guan H; Jiang Y; Jiang Q Mol Biol Rep; 2022 Sep; 49(9):8575-8586. PubMed ID: 35834034 [TBL] [Abstract][Full Text] [Related]
2. Down-regulation of microRNA-155 attenuates retinal neovascularization via the PI3K/Akt pathway. Zhuang Z; Xiao-qin ; Hu H; Tian SY; Lu ZJ; Zhang TZ; Bai YL Mol Vis; 2015; 21():1173-84. PubMed ID: 26539029 [TBL] [Abstract][Full Text] [Related]
3. Acute downregulation of miR-155 leads to a reduced collagen synthesis through attenuating macrophages inflammatory factor secretion by targeting SHIP1. Yang L; Liu L; Ying H; Yu Y; Zhang D; Deng H; Zhang H; Chai J J Mol Histol; 2018 Apr; 49(2):165-174. PubMed ID: 29330743 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of microRNA-138 alleviates human coronary artery endothelial cell injury and inflammatory response by inhibiting the PI3K/Akt/eNOS pathway. Li JB; Wang HY; Yao Y; Sun QF; Liu ZH; Liu SQ; Zhuang JL; Wang YP; Liu HY J Cell Mol Med; 2017 Aug; 21(8):1482-1491. PubMed ID: 28371277 [TBL] [Abstract][Full Text] [Related]
5. ORF3a of SARS-CoV-2 modulates PI3K/AKT signaling in human lung epithelial cells via hsa-miR-155-5p. Ahmad F; Keshri V; Singh SK Int J Biol Macromol; 2024 May; 268(Pt 1):131734. PubMed ID: 38653431 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of MicroRNA-155 aggravates pulpitis by targeting kinesin superfamily Proteins-5C based on illumina high-throughput sequencing. Jiang Y; He Y; Chen Y; Zeng J; Huang W; Huang L; Luo J; Ma Y; Wu L; Yang X Int Endod J; 2023 Jul; 56(7):837-853. PubMed ID: 37070646 [TBL] [Abstract][Full Text] [Related]
7. Mechanism of miR-122-5p regulating the activation of PI3K-Akt-mTOR signaling pathway on the cell proliferation and apoptosis of osteosarcoma cells through targeting TP53 gene. Li KW; Wang SH; Wei X; Hou YZ; Li ZH Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12655-12666. PubMed ID: 33378012 [TBL] [Abstract][Full Text] [Related]
8. microRNA-107 inhibits gastric cancer cell proliferation and metastasis by targeting PI3K/AKT pathway. Cheng F; Yang Z; Huang F; Yin L; Yan G; Gong G Microb Pathog; 2018 Aug; 121():110-114. PubMed ID: 29715534 [TBL] [Abstract][Full Text] [Related]
9. Stimulation phosphatidylinositol 3-kinase/protein kinase B signaling by Porphyromonas gingivalis lipopolysacch aride mediates interleukin-6 and interleukin-8 mRNA/protein expression in pulpal inflammation. Tsai YL; Wang CY; Chuang FH; Pan YH; Lin YR; Dhingra K; Liao PS; Huang FS; Chang MC; Jeng JH J Formos Med Assoc; 2023 Jan; 122(1):47-57. PubMed ID: 36031486 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-181b attenuates lipopolysaccharide-induced inflammatory responses in pulpitis via the PLAU/AKT/NF-κB axis. Meng T; Liu X; Zhang J; Li S; He W; Li W Int Immunopharmacol; 2024 Jan; 127():111451. PubMed ID: 38154211 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-200a Affects the Proliferation of Airway Smooth Muscle Cells and Airway Remodeling by Targeting FOXC1 via the PI3K/AKT Signaling Pathway in Ovalbumin-Induced Asthmatic Mice. Liu Y; Miao Y; Gao X; Wang YY; Wang H; Zheng YW; Zhao ZY Cell Physiol Biochem; 2018; 50(6):2365-2389. PubMed ID: 30423573 [TBL] [Abstract][Full Text] [Related]
12. Elevated miR-155 promotes inflammation in cystic fibrosis by driving hyperexpression of interleukin-8. Bhattacharyya S; Balakathiresan NS; Dalgard C; Gutti U; Armistead D; Jozwik C; Srivastava M; Pollard HB; Biswas R J Biol Chem; 2011 Apr; 286(13):11604-15. PubMed ID: 21282106 [TBL] [Abstract][Full Text] [Related]
13. Down-regulated ciRS-7/up-regulated miR-7 axis aggravated cartilage degradation and autophagy defection by PI3K/AKT/mTOR activation mediated by IL-17A in osteoarthritis. Zhou X; Li J; Zhou Y; Yang Z; Yang H; Li D; Zhang J; Zhang Y; Xu N; Huang Y; Jiang L Aging (Albany NY); 2020 Oct; 12(20):20163-20183. PubMed ID: 33099538 [TBL] [Abstract][Full Text] [Related]
14. Reduced expression and activity of patient-derived SHIP1 phosphatase domain mutants. Ehm P; Nelson N; Giehler S; Schaks M; Bettin B; Kirchmair J; Jücker M Cell Signal; 2023 Jan; 101():110485. PubMed ID: 36208705 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma. Chen HX; Xu XX; Tan BZ; Zhang Z; Zhou XD Cell Physiol Biochem; 2017; 41(3):933-946. PubMed ID: 28222438 [TBL] [Abstract][Full Text] [Related]
16. SHIP1 is targeted by miR-155 in acute myeloid leukemia. Xue H; Hua LM; Guo M; Luo JM Oncol Rep; 2014 Nov; 32(5):2253-9. PubMed ID: 25175984 [TBL] [Abstract][Full Text] [Related]
17. SHIP1 inhibits cell growth, migration, and invasion in non‑small cell lung cancer through the PI3K/AKT pathway. Fu Q; Huang Y; Ge C; Li Z; Tian H; Li Q; Li H; Li R; Tao X; Xue Y; Wang Y; Yang G; Fang W; Song X Oncol Rep; 2019 Apr; 41(4):2337-2350. PubMed ID: 30720128 [TBL] [Abstract][Full Text] [Related]
18. Jarid1b promotes epidermal differentiation by mediating the repression of Ship1 and activation of the AKT/Ovol1 pathway. Sun X; Li Z; Niu Y; Zhao L; Huang Y; Li Q; Zhang S; Chen T; Fu T; Yang T; An X; Jiang Y; Zhang J Cell Prolif; 2019 Sep; 52(5):e12638. PubMed ID: 31152465 [TBL] [Abstract][Full Text] [Related]
19. Prediction and verification of target of helenalin against hepatic stellate cell activation based on miR-200a-mediated PI3K/Akt and NF-κB pathways. Fang B; Wen S; Li Y; Bai F; Wei Y; Xiong Y; Huang Q; Lin X Int Immunopharmacol; 2021 Mar; 92():107208. PubMed ID: 33444919 [TBL] [Abstract][Full Text] [Related]
20. miR-33-5p knockdown attenuates abdominal aortic aneurysm progression via promoting target adenosine triphosphate-binding cassette transporter A1 expression and activating the PI3K/Akt signaling pathway. Zhao L; Huang J; Zhu Y; Han S; Qing K; Wang J; Feng Y Perfusion; 2020 Jan; 35(1):57-65. PubMed ID: 31170866 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]